BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35764718)

  • 21. Sumoylation is involved in beta-catenin-dependent activation of Tcf-4.
    Yamamoto H; Ihara M; Matsuura Y; Kikuchi A
    EMBO J; 2003 May; 22(9):2047-59. PubMed ID: 12727872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An RNA aptamer that binds to the beta-catenin interaction domain of TCF-1 protein.
    Lee SK; Park MW; Yang EG; Yu J; Jeong S
    Biochem Biophys Res Commun; 2005 Feb; 327(1):294-9. PubMed ID: 15629461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TCF-4 Regulated lncRNA-XIST Promotes M2 Polarization Of Macrophages And Is Associated With Lung Cancer.
    Sun Y; Xu J
    Onco Targets Ther; 2019; 12():8055-8062. PubMed ID: 31632059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib-induced degradation of T-cell factors-1 and -4 in human colon cancer cells.
    Takahashi-Yanaga F; Yoshihara T; Jingushi K; Miwa Y; Morimoto S; Hirata M; Sasaguri T
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1185-90. PubMed ID: 18983819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box.
    van de Wetering M; Oosterwegel M; Dooijes D; Clevers H
    EMBO J; 1991 Jan; 10(1):123-32. PubMed ID: 1989880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition.
    Held W; Clevers H; Grosschedl R
    Eur J Immunol; 2003 May; 33(5):1393-8. PubMed ID: 12731066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TCF-1 and HEB cooperate to establish the epigenetic and transcription profiles of CD4
    Emmanuel AO; Arnovitz S; Haghi L; Mathur PS; Mondal S; Quandt J; Okoreeh MK; Maienschein-Cline M; Khazaie K; Dose M; Gounari F
    Nat Immunol; 2018 Dec; 19(12):1366-1378. PubMed ID: 30420627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin.
    Miravet S; Piedra J; Miró F; Itarte E; García de Herreros A; Duñach M
    J Biol Chem; 2002 Jan; 277(3):1884-91. PubMed ID: 11711551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradation of the Organophosphate Trichlorfon and Its Major Degradation Products by a Novel Aspergillus sydowii PA F-2.
    Tian J; Dong Q; Yu C; Zhao R; Wang J; Chen L
    J Agric Food Chem; 2016 Jun; 64(21):4280-7. PubMed ID: 27161040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of LEF/TCF factors in neoplastic transformation.
    Ravindranath A; O'Connell A; Johnston PG; El-Tanani MK
    Curr Mol Med; 2008 Feb; 8(1):38-50. PubMed ID: 18289012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer.
    Shulewitz M; Soloviev I; Wu T; Koeppen H; Polakis P; Sakanaka C
    Oncogene; 2006 Jul; 25(31):4361-9. PubMed ID: 16532032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the clinicopathological features and oncologic outcomes of the classic papillary thyroid carcinoma with tall cell features and tall cell variant.
    Kim K; Jung CK; Lim DJ; Bae JS; Kim JS
    Gland Surg; 2022 Jan; 11(1):56-66. PubMed ID: 35242669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability.
    Duval A; Gayet J; Zhou XP; Iacopetta B; Thomas G; Hamelin R
    Cancer Res; 1999 Sep; 59(17):4213-5. PubMed ID: 10485457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of a tumor cytolytic factor(s) by activated human alveolar macrophages and its action.
    Sone S; Tachibana K; Ishii K; Ogawara M; Tsubura E
    Cancer Res; 1984 Feb; 44(2):646-51. PubMed ID: 6692369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ELISA for F-TCF (human hepatocyte growth factor/hHGF)/fibroblast-derived tumor cytotoxic factor antigen employing monoclonal antibodies and its application to patients with liver diseases.
    Shima N; Higashio K; Ogaki H; Okabe K
    Gastroenterol Jpn; 1991 Aug; 26(4):477-82. PubMed ID: 1833258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
    Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
    Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.
    Park CH; Hahm ER; Park S; Kim HK; Yang CH
    FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LvGroucho and nuclear beta-catenin functionally compete for Tcf binding to influence activation of the endomesoderm gene regulatory network in the sea urchin embryo.
    Range RC; Venuti JM; McClay DR
    Dev Biol; 2005 Mar; 279(1):252-67. PubMed ID: 15708573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
    Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of T cell factor-4 in non-small-cell lung cancer.
    Li CY; Wang Y; Cui ZS; Wang EH
    Chin Med J (Engl); 2005 Jan; 118(2):136-40. PubMed ID: 15667799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.